➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
AstraZeneca
McKesson
Medtronic
Mallinckrodt

Last Updated: January 22, 2021

DrugPatentWatch Database Preview

Litigation Details for Cubist Pharmaceuticals Inc. v. Hospira Inc. (D. Del. 2012)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Cubist Pharmaceuticals Inc. v. Hospira Inc. (D. Del. 2012)

Docket   Start Trial Date Filed 2012-09-17
Court District Court, D. Delaware Date Terminated 2015-06-22
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties CUBIST PHARMACEUTICALS INC.; HOSPIRA INC.
Patents 6,468,967; 6,852,689; 8,058,238; 8,129,342; RE39,071
Attorneys Derek James Fahnestock; Jack B. Blumenfeld; John C. Phillips , Jr.; Maryellen Noreika
Link to Docket External link to docket
Small Molecule Drugs cited in Cubist Pharmaceuticals Inc. v. Hospira Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Cubist Pharmaceuticals Inc. v. Hospira Inc. (D. Del. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-09-17 1 10. United States Patent No. 6,468,967 (“the ’967 patent”), entitled “Methods for Administration…CUBICIN® prior to the expiration of U.S. Patent Nos. 6,468,967; 6,852,689; RE39,071; 8,058,238; and 8,… INFRINGEMENT OF U.S. PATENT NO. 6,468,967 19. Plaintiff incorporates… 1. This is an action for patent infringement under the patent laws of the United States, Title… 11. United States Patent No. 6,852,689 (“the ’689 patent”), entitled “Methods for Administration External link to document
2012-09-17 3 /10/2012. Date of Expiration of Patent: 6,658,967-9/24/2019;6,852,689-9/24/2019;RE39,071-6/15/2016;8,058,238… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2012 22 June 2015 1:12-cv-01142 830 Patent None District Court, D. Delaware External link to document
2012-09-17 4 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,568,967 B1; 6,852,689 B2; RE39,071…2012 22 June 2015 1:12-cv-01142 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Mallinckrodt
Baxter
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.